Atazanavir sulphate
- 1 November 2003
- journal article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 2 (11) , 857-858
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Toxicity of antiretroviral therapy and implications for drug developmentNature Reviews Drug Discovery, 2003
- Twenty years of therapy for HIV-1 infectionNature Medicine, 2003
- Nelfinavir, Efavirenz, or Both after the Failure of Nucleoside Treatment of HIV InfectionNew England Journal of Medicine, 2001
- BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral AgentsAntimicrobial Agents and Chemotherapy, 2000
- New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical DevelopmentJournal of Medicinal Chemistry, 1998
- Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral BioavailabilityJournal of Medicinal Chemistry, 1996
- Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitorStructure, 1995